SCHEMBL6804333

SCHEMBL6804333

CCc1ccc(-c2ccccc2C(=O)Nc2ccc3c(c2)CCN3C(=O)Cc2ccnc(-n3c(C)ccc3C)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 1/20 0.39
CREBBP Q92793 1/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
EIF2AK3 Q9NZJ5 3/20 0.38
RIPK1 Q13546 1/20 0.38
AVPR2 P30518 2/20 0.37
AVPR1A P37288 2/20 0.37
OXTR P30559 1/20 0.37
SMO Q99835 1/20 0.37
EIF2AK1 Q9BQI3 1/20 0.37
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
SYK P43405 2/20 0.37
NPY2R P49146 2/20 0.36
PDE7A Q13946 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6804782 0.94 MAPT (0.43) CREBBPMAPTEIF2AK3RIPK1AVPR2
SCHEMBL6665477 0.92 CYP11B1 (0.38) KLK7CREBBPMAPTMEN1KMT2A
SCHEMBL6804557 0.90 SMO (0.47) SMOSMN1; SMN2
SCHEMBL6803618 0.88 RIPK1 (0.40) KLK7CREBBPMAPTMEN1KMT2A
SCHEMBL6805312 0.88 EIF2AK3 (0.43) KLK7CREBBPEIF2AK3RIPK1AVPR2
SCHEMBL6672281 0.86 EIF2AK3 (0.49) CREBBPMEN1KMT2AEIF2AK3AVPR2
SCHEMBL6669306 0.84 HTR2A (0.40) MAPTEIF2AK3RIPK1SMOSYK
SCHEMBL6803323 0.84 EIF2AK3 (0.43) KLK7CREBBPMAPTMEN1KMT2A
SCHEMBL6804764 0.82 MAPT (0.44) CREBBPMAPTEIF2AK3RIPK1AVPR2
SCHEMBL6804990 0.81 MAPT (0.44) CREBBPMAPTEIF2AK3RIPK1AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 KLK7 3950/4885CREBBP 1901/4885MAPT 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.